| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $488.4M | +0.1% |
| Cost of Revenue | $272.9M | +2.8% |
| Gross Profit | $215.5M | -3.2% |
| R&D Expense | $38.2M | -13.6% |
| SG&A Expense | $67.5M | +20.8% |
| Operating Income | -$98.0M | -342.9% |
| Pre-tax Income | -$97.9M | -343.6% |
| Income Tax | $5.6M | -18.0% |
| Net Income | -$103.5M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $56.6M | -14.2% |
| Short-term Investments | $23.6M | +103.5% |
| Accounts Receivable | $76.2M | -4.8% |
| Inventory | $13.6M | +3.2% |
| Current Assets | $186.6M | +1.7% |
| Total Assets | $802.2M | -13.6% |
| Current Liabilities | $71.6M | +30.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $62.1M | +12.4% |
| Capital Expenditures | $21.7M | -36.6% |
| Investing Cash Flow | -$43.1M | +54.5% |
| Financing Cash Flow | -$27.9M | -25.8% |
| Free Cash Flow | $40.4M | +92.0% |
| -410.0% |
| EPS (Basic) | -$3.77 | -411.6% |
| EPS (Diluted) | -$3.77 | -411.6% |
| Total Liabilities |
| $104.5M |
| +4.4% |
| Stockholders' Equity | $697.6M | -15.8% |